Clinical trial
Irofulven in Treating Patients With Stage IV Melanoma
NCT00005968 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00005968 |
|---|---|
| Title | Irofulven in Treating Patients With Stage IV Melanoma |
| Official title | A Multicenter Phase II Trial of MGI-114 in Patients With Stage IV Malignant Melanoma |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | irofulven |
| Start date | Nov 1, 1999 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Jun 21, 2004 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: